Tamarack Advisers’s DermTech, Inc. Common Stock DMTK Stock Holding History

Tamarack Advisers’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-175,000	Closed	-$693K	–	49
2022 Q3	$693K	Buy	175,000 +75,000	+75%	+$461K	0.41%	37
2022 Q2	$554K	Buy	100,000 +50,000	+100%	+$409K	0.32%	34
2022 Q1	$734K	Buy	+50,000	New	+$669K	0.35%	38
2021 Q4	–	Sell	-85,000	Closed	-$2.73M	–	59
2021 Q3	$2.73M	Sell	85,000 -50,000	-37%	-$1.76M	0.86%	29
2021 Q2	$5.61M	Buy	135,000 +51,000	+61%	+$2.09M	1.59%	26
2021 Q1	$4.27M	Buy	84,000 +59,000	+236%	+$3.09M	0.88%	32
2020 Q4	$798K	Buy	+25,000	New	+$354K	0.17%	40

Other funds holding DMTK

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EPIQ Partners Minneapolis, Minnesota $236M AUM 15.39% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tamarack Advisers's DMTK Position: Q4 2022 in Review

Tamarack Advisers sold out of DermTech, Inc. Common Stock (DMTK) in Q4 2022, closing a stake of 175,000 shares — an estimated $693K sold.

Tamarack Advisers first reported a position in DMTK in Q4 2020 and held it in 7 quarters. The position peaked at $5.61M in Q2 2021. 94 funds tracked by Wall St. Rank hold DMTK as of Q4 2022.

Tamarack Advisers reported no remaining DermTech, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Tamarack Advisers sold 175,000 DermTech, Inc. Common Stock shares in Q4 2022, an estimated $693K.
Tamarack Advisers first reported a position in DermTech, Inc. Common Stock in Q4 2020 and held it in 7 quarters.
Tamarack Advisers's DermTech, Inc. Common Stock position peaked at $5.61M in Q2 2021.
94 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q4 2022.

Based on Tamarack Advisers's 13F filing for Q4 2022, filed 13 Feb 2023.